Teikoku Pharma USA announced that it has submitted a New Drug Application (NDA) to the Food and Drug Administration (FDA) for Docetaxel Injection Concentrate, Non-Alcohol Formula for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback